New Compound Dramatically Reduces Joint Inflammation, The Scripps Research Institute Study

Published: Dec 11, 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

An experimental compound synthesized and developed by scientists from the Florida campus of The Scripps Research Institute (TSRI) has the capacity to significantly reduce joint inflammation in animal models of rheumatoid arthritis, an autoimmune disease that affects more than two million Americans. The study was published recently online ahead of print by the journal Arthritis & Rheumatism.

Hey, check out all the research scientist jobs. Post your resume today!

Back to news